These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment. Takasawa K; Kubota N; Terauchi Y; Kadowaki T Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083 [TBL] [Abstract][Full Text] [Related]
7. Effect of diosgenin on metabolic dysfunction: Role of ERβ in the regulation of PPARγ. Wang X; Liu J; Long Z; Sun Q; Liu Y; Wang L; Zhang X; Hai C Toxicol Appl Pharmacol; 2015 Dec; 289(2):286-96. PubMed ID: 26408789 [TBL] [Abstract][Full Text] [Related]
8. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity. Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome Proliferator-Activated Receptor γ and Its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization. Wang QA; Zhang F; Jiang L; Ye R; An Y; Shao M; Tao C; Gupta RK; Scherer PE Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29483301 [TBL] [Abstract][Full Text] [Related]
10. The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. Li YY; Wu HS; Tang L; Feng CR; Yu JH; Li Y; Yang YS; Yang B; He QJ Pharmacol Res; 2007 Oct; 56(4):335-43. PubMed ID: 17889553 [TBL] [Abstract][Full Text] [Related]
11. Lack of CUL4B in Adipocytes Promotes PPARγ-Mediated Adipose Tissue Expansion and Insulin Sensitivity. Li P; Song Y; Zan W; Qin L; Han S; Jiang B; Dou H; Shao C; Gong Y Diabetes; 2017 Feb; 66(2):300-313. PubMed ID: 27899484 [TBL] [Abstract][Full Text] [Related]
12. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes. Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920 [TBL] [Abstract][Full Text] [Related]
13. Cystathionine γ lyase-hydrogen sulfide increases peroxisome proliferator-activated receptor γ activity by sulfhydration at C139 site thereby promoting glucose uptake and lipid storage in adipocytes. Cai J; Shi X; Wang H; Fan J; Feng Y; Lin X; Yang J; Cui Q; Tang C; Xu G; Geng B Biochim Biophys Acta; 2016 May; 1861(5):419-29. PubMed ID: 26946260 [TBL] [Abstract][Full Text] [Related]
14. Heterozygous deletion of Seipin in islet beta cells of male mice has an impact on insulin synthesis and secretion through reduced PPARγ expression. Xiong J; Sun P; Wang Y; Hua X; Song W; Wang Y; Wu J; Yu W; Liu G; Chen L Diabetologia; 2020 Feb; 63(2):338-350. PubMed ID: 31776610 [TBL] [Abstract][Full Text] [Related]
15. The effect of PPARgamma ligands on the adipose tissue in insulin resistance. Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183 [TBL] [Abstract][Full Text] [Related]
16. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation. Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867 [TBL] [Abstract][Full Text] [Related]
17. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. Yamauchi T; Kamon J; Waki H; Murakami K; Motojima K; Komeda K; Ide T; Kubota N; Terauchi Y; Tobe K; Miki H; Tsuchida A; Akanuma Y; Nagai R; Kimura S; Kadowaki T J Biol Chem; 2001 Nov; 276(44):41245-54. PubMed ID: 11533050 [TBL] [Abstract][Full Text] [Related]